Skip to main content

Table 4 Logistic regression analysis of predictors associated with favorable clinical outcome in 132 patients with VAP

From: Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study

  Multivariate analysis
Variables OR 95% CI p value
IH plus IV polymyxin B 2.63 1.06–6.66 0.037
SOFA score 0.87 0.79–0.96 0.005
Septic shock 0.40 0.18–0.91 0.028